These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 6217586)
1. Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules. Jandrot-Perrus M; Aurousseau MH; Rabiet MJ; Josso F Thromb Res; 1982 Sep; 27(6):659-70. PubMed ID: 6217586 [TBL] [Abstract][Full Text] [Related]
2. Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A. Matsuda M; Saeki E; Kasamatsu A; Nakamikawa C; Manabe S; Samejima Y Thromb Res; 1985 Feb; 37(3):379-90. PubMed ID: 3992527 [TBL] [Abstract][Full Text] [Related]
3. Fibrinogen Aarhus--a new case of dysfibrinogenemia. Hessel B; Stenbjerg S; Dyr J; Kudryk B; Therkildsen L; Blombäck B Thromb Res; 1986 Apr; 42(1):21-37. PubMed ID: 2939591 [TBL] [Abstract][Full Text] [Related]
4. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine. Yoshida N; Wada H; Morita K; Hirata H; Matsuda M; Yamazumi K; Asakura S; Shirakawa S Blood; 1991 May; 77(9):1958-63. PubMed ID: 2018836 [TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Seattle II: defective release of fibrinopeptide A in a slow clotting fibrinogen. Schreiber WE; Schmer G Thromb Res; 1985 Jan; 37(1):45-52. PubMed ID: 3983901 [TBL] [Abstract][Full Text] [Related]
7. Fibrinogen Barcelona I. Congenital dysfibrinogenemia characterized by defective release of fibrinopeptide A and fibrinogen degradation products. Vila V; Regañón E; Aznar J; Navarro G; Salas M Thromb Res; 1987 Mar; 45(5):437-49. PubMed ID: 2954261 [TBL] [Abstract][Full Text] [Related]
8. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide. Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702 [TBL] [Abstract][Full Text] [Related]
9. A kinetic method for characterization of heterogenous fibrinogen and its application to fibrinogen Grand Rapids, a congenital dysfibrinogenemia. Higgins DL; Lewis SD; Penner JA; Shafer JA Thromb Haemost; 1982 Oct; 48(2):182-6. PubMed ID: 6217579 [TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro). Meyer M; Kutscher G; Stürzebecher J; Riesener G; Lutze G Thromb Res; 2003 Jan; 109(2-3):145-51. PubMed ID: 12706644 [TBL] [Abstract][Full Text] [Related]
12. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency. Bögli C; Cofrancesco E; Cortellaro M; Della Volpe A; Hofer A; Furlan M; Zanussi C Eur J Haematol; 1990 Jul; 45(1):26-30. PubMed ID: 2379562 [TBL] [Abstract][Full Text] [Related]
13. Fibrinogen New Orleans: hereditary dysfibrinogenemia with an A alpha chain abnormality. Andes WA; Chavin SI; Beltran G; Stuckey WJ Thromb Res; 1982 Jan 1-15; 25(1-2):41-50. PubMed ID: 6801812 [TBL] [Abstract][Full Text] [Related]
14. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization. Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560 [TBL] [Abstract][Full Text] [Related]
15. Fibrinogen Seattle releases half the normal amount of fibrinopeptide B. Branson HE; Schmer G; Theodor I; Pirkle H Acta Haematol; 1983; 70(4):257-63. PubMed ID: 6414212 [TBL] [Abstract][Full Text] [Related]
16. The impact of delayed fibrinopeptide-A release on fibrin structure. Studies of an abnormal fibrinogen. Carr ME; Qureshi GD J Biol Chem; 1987 Nov; 262(32):15568-74. PubMed ID: 3680212 [TBL] [Abstract][Full Text] [Related]
17. Fibrinogen Sevilla, a congenital dysfibrinogenemia characterized by an abnormal monomer aggregation and a defective plasmin lysis. Fernández FJ; Noguerol P; Sosa R; Cuesta B; Páramo JA; Rocha E Clin Chim Acta; 1989 Feb; 179(3):239-50. PubMed ID: 2713997 [TBL] [Abstract][Full Text] [Related]
18. Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation. Rodeghiero F; Castaman GC; Dal Belin Peruffo A; Dini E; Galletti A; Barone E; Gastaldi G Thromb Haemost; 1987 Jun; 57(3):252-8. PubMed ID: 2958952 [TBL] [Abstract][Full Text] [Related]
19. Fibrinogen Petoskey: identification of a new dysfibrinogenemia characterized by altered release of fibrinopeptide A. Higgins DL; Penner JA; Shafer JA Thromb Res; 1981 Sep; 23(6):491-504. PubMed ID: 6459662 [No Abstract] [Full Text] [Related]
20. Characterization of fibrinogen Milano I: amino acid exchange gamma 330 Asp----Val impairs fibrin polymerization. Reber P; Furlan M; Rupp C; Kehl M; Henschen A; Mannucci PM; Beck EA Blood; 1986 Jun; 67(6):1751-6. PubMed ID: 3708159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]